Ola Landgren


Ontology type: schema:Person     


Person Info

NAME

Ola

SURNAME

Landgren

Publications in SciGraph latest 50 shown

  • 2018-12 Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma in NATURE MEDICINE
  • 2018-09 Biological determinants of health disparities in multiple myeloma in BLOOD CANCER JOURNAL
  • 2018-06 Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms in MODERN PATHOLOGY
  • 2018-05-04 Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma in BONE MARROW TRANSPLANTATION
  • 2018 Epidemiology and Pathophysiology of Multiple Myeloma in MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS
  • 2018 Monoclonal Gammopathy of Undetermined Significance in NEOPLASTIC DISEASES OF THE BLOOD
  • 2017-10-20 Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey in BLOOD CANCER JOURNAL
  • 2017-07 Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-02 History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study in ANNALS OF HEMATOLOGY
  • 2017 Plasma Cell Myeloma and Plasma Cell Disorders in AJCC CANCER STAGING MANUAL
  • 2017 Epidemiology of Waldenström Macroglobulinemia in WALDENSTRÖM’S MACROGLOBULINEMIA
  • 2016-12 Imaging Measurable (Minimal) Residual Disease in Multiple Myeloma in CURRENT RADIOLOGY REPORTS
  • 2016-12 Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis in BONE MARROW TRANSPLANTATION
  • 2016-12 Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III in BMC GASTROENTEROLOGY
  • 2016-07 MRD-driven treatment paradigm for newly diagnosed transplant eligible multiple myeloma patients in BONE MARROW TRANSPLANTATION
  • 2016-05 Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study in ANNALS OF HEMATOLOGY
  • 2016-04 Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study in BONE MARROW TRANSPLANTATION
  • 2016 MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology in PLASMA CELL DYSCRASIAS
  • 2015-07 The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies in BLOOD CANCER JOURNAL
  • 2015-06 Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case–control study from Sweden in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2015-05 Minimal residual disease in multiple myeloma: bringing the bench to the bedside in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2015-04 The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies in BLOOD CANCER JOURNAL
  • 2015-03 Trends and Racial/Ethnic Disparities in Gluten-Sensitive Problems in the United States: Findings from the National Health and Nutrition Examination Surveys From 1988 to 2012 in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2015-01 Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients in BONE MARROW TRANSPLANTATION
  • 2014-12 Risk of myeloid neoplasms after solid organ transplantation in LEUKEMIA
  • 2014-09 MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström’s Macroglobulinemia in LEUKEMIA
  • 2014-07 Update on second primary malignancies in multiple myeloma: a focused review in LEUKEMIA
  • 2014-07 Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey in LEUKEMIA
  • 2014-06 Bildgebung bei „smoldering“ (asymptomatischem) multiplem Myelom in DER RADIOLOGE
  • 2014-06 Improved long-term survival in multiple myeloma up to the age of 80 years in LEUKEMIA
  • 2014-03 Inherited genetic susceptibility to multiple myeloma in LEUKEMIA
  • 2014-02 Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial in LEUKEMIA
  • 2014-01 Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance in LEUKEMIA
  • 2013-11 Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases in ANNALS OF HEMATOLOGY
  • 2013-04 Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group in LEUKEMIA
  • 2013 Genetics in Lymphomagenesis in NEOPLASTIC DISEASES OF THE BLOOD
  • 2013-01 Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS in LEUKEMIA
  • 2012-04 Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma in LEUKEMIA
  • 2012-01 Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study in LEUKEMIA
  • 2010-12 Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome in BMC MEDICAL GENETICS
  • 2010-06 Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management in LEUKEMIA
  • 2010-03 Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management in LEUKEMIA
  • 2009-12 Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms in GENOME MEDICINE
  • 2009-10 Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis in LEUKEMIA
  • 2009-10 Timing of births and endometrial cancer risk in Swedish women in CANCER CAUSES & CONTROL
  • 2009-03 Risks of myeloid malignancies in patients with autoimmune conditions in BRITISH JOURNAL OF CANCER
  • 2005-03 Mantle cell lymphomas with clonal immunoglobulin VH3–21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin VH genes in MODERN PATHOLOGY
  • 2004 A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. in HAEMATOLOGICA
  • 2000-08 Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease in MEDICAL ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.51462.34", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417768.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420086.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.62562.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419635.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412650.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417390.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.94365.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.241167.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1005.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420089.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4714.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.24381.3c", 
            "type": "Organization"
          }
        ], 
        "familyName": "Landgren", 
        "givenName": "Ola", 
        "id": "sg:person.0651746766.54", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0001-6485-4839"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651746766.54", 
          "https://orcid.org/0000-0001-6485-4839"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:59", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_689.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0651746766.54'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0651746766.54'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0651746766.54'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0651746766.54'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      11 PREDICATES      30 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0651746766.54 schema:affiliation Nc68a5150bc78401aa3f2e017b5e5583d
    2 https://www.grid.ac/institutes/grid.1005.4
    3 https://www.grid.ac/institutes/grid.241167.7
    4 https://www.grid.ac/institutes/grid.24381.3c
    5 https://www.grid.ac/institutes/grid.412650.4
    6 https://www.grid.ac/institutes/grid.417390.8
    7 https://www.grid.ac/institutes/grid.417768.b
    8 https://www.grid.ac/institutes/grid.419635.c
    9 https://www.grid.ac/institutes/grid.420086.8
    10 https://www.grid.ac/institutes/grid.420089.7
    11 https://www.grid.ac/institutes/grid.4714.6
    12 https://www.grid.ac/institutes/grid.48336.3a
    13 https://www.grid.ac/institutes/grid.5386.8
    14 https://www.grid.ac/institutes/grid.62562.35
    15 https://www.grid.ac/institutes/grid.66875.3a
    16 https://www.grid.ac/institutes/grid.7445.2
    17 https://www.grid.ac/institutes/grid.7497.d
    18 https://www.grid.ac/institutes/grid.94365.3d
    19 schema:familyName Landgren
    20 schema:givenName Ola
    21 schema:identifier N5452a9185f3e4dda8296f2aab7b7d34b
    22 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651746766.54
    23 https://orcid.org/0000-0001-6485-4839
    24 schema:sdDatePublished 2019-03-07T14:59
    25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    26 schema:sdPublisher N7431b9925c8644489ed13625b828e01c
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset persons
    29 rdf:type schema:Person
    30 N5452a9185f3e4dda8296f2aab7b7d34b schema:name orcid_id
    31 schema:value 0000-0001-6485-4839
    32 rdf:type schema:PropertyValue
    33 N7431b9925c8644489ed13625b828e01c schema:name Springer Nature - SN SciGraph project
    34 rdf:type schema:Organization
    35 Nc68a5150bc78401aa3f2e017b5e5583d schema:affiliation https://www.grid.ac/institutes/grid.51462.34
    36 sgo:isCurrent true
    37 rdf:type schema:OrganizationRole
    38 https://www.grid.ac/institutes/grid.1005.4 schema:Organization
    39 https://www.grid.ac/institutes/grid.241167.7 schema:Organization
    40 https://www.grid.ac/institutes/grid.24381.3c schema:Organization
    41 https://www.grid.ac/institutes/grid.412650.4 schema:Organization
    42 https://www.grid.ac/institutes/grid.417390.8 schema:Organization
    43 https://www.grid.ac/institutes/grid.417768.b schema:Organization
    44 https://www.grid.ac/institutes/grid.419635.c schema:Organization
    45 https://www.grid.ac/institutes/grid.420086.8 schema:Organization
    46 https://www.grid.ac/institutes/grid.420089.7 schema:Organization
    47 https://www.grid.ac/institutes/grid.4714.6 schema:Organization
    48 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    49 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    50 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
    51 https://www.grid.ac/institutes/grid.62562.35 schema:Organization
    52 https://www.grid.ac/institutes/grid.66875.3a schema:Organization
    53 https://www.grid.ac/institutes/grid.7445.2 schema:Organization
    54 https://www.grid.ac/institutes/grid.7497.d schema:Organization
    55 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...